7 things to know before Saroja Pharma Industries India Limited

ipo - saroja pharma industries

Overview of company:

  • Saroja Pharma Industries India Limited IPO was incorporated in 2019.
  • The company is involved in trading, exporting, and supplying Specialty Chemicals & Active Pharmaceutical Ingredients (API).

Product Categories: The company deals in three distinct product categories:

  1. Chemical: Trading of various chemicals.
  2. Pharma Intermediary: Supply of pharmaceutical intermediaries.
  3. Veterinary Pharma API: Providing APIs for veterinary pharmaceuticals.

Product Range:

  • The company offers a range of products including Liquide Bromine, used as an agro-intermediate.
  • Ethyl Acetate, which serves as an API solvent.
  • Various pharmaceuticals intended for human and veterinary drugs.
  • Some of these products also function as API solvents.

Role of APIs:

  • APIs, or Active Pharmaceutical Ingredients, are the primary components used in creating finished dosages like capsules, tablets, liquids, and other forms of dosage.
  • APIs are combined with other APIs or inactive ingredients to produce the final pharmaceutical products.

Export Markets:

  • The company primarily exports its products to countries including Pakistan, Egypt, Russia, Jordan, Hong Kong, and Singapore.

Competitive Strength:

  • Experienced Promoters and Management Team
  • Scalable Business Model
  • Wide and diverse range of product offerings
  • Diversified business operations and revenue base

Saroja Pharma Industries IPO Details

Saroja Pharma Industries IPO Details:

  • The Saroja Pharma Industries IPO is categorized as a Fixed Price Issue.
  • The total issue size of the IPO is Rs 9.11 Crores.
  • The Saroja Pharma Industries IPO price is set at ₹84 per share.

IPO DateAug 31, 2023 to Sep 5, 2023
Listing DateWednesday, 13 September 2023
Face Value₹10 per share
Price₹84 per share
Lot Size1600 Shares
Total Issue Size1,084,800 shares
(aggregating up to ₹9.11 Cr)
Fresh Issue1,084,800 shares
(aggregating up to ₹9.11 Cr)

Saroja Pharma Industries IPO Timetable (Tentative)

IPO Open DateThursday, 31 August 2023
IPO Close DateTuesday, 5 September 2023
Basis of AllotmentFriday, 8 September 2023
Initiation of RefundsMonday, 11 September 2023
Credit of Shares to DematTuesday, 12 September 2023
Listing DateWednesday, 13 September 2023
Cut-off time for UPI mandate confirmation5 PM on Sep 5, 2023

Key Performance Indicator

P/E (x)23.27
EPS (Rs)3.61

Saroja Pharma Industries Promoter Holding

Pre Issue Share Holding

Post Issue Share Holding

Saroja Pharma Industries Lot Size

Retail (Min)11600₹134,400
Retail (Max)11600₹134,400
HNI (Min)23200₹268,800

Financials of the Company:

Period Ended31 Mar 202131 Mar 202231 Mar 2023
Profit After Tax73.13114.01106.06
Net Worth93.59402.60508.66
Reserves and Surplus92.59380.02215.09
Total Borrowing301.77613.881,018.86
Amount in ₹ Lakhs

Objects of the Issue:

Utilization of Proceeds from Fresh Issue: The proceeds generated from the Fresh Issue will be allocated for the following purposes:

  1. Setting up a Manufacturing Unit: The funds will be used to establish a new manufacturing facility.
  2. Repayment of Unsecured Loans: Part of the proceeds will be utilized to repay existing unsecured loans.
  3. Public Issue Expenses: The funds will also cover the expenses related to the public issue.

Saroja Pharma Industries IPO Review (I am Avoiding)

SPIIL is presently engaged in trading specialty chemicals and pharma APIs. Despite its plans to venture into manufacturing, its financial performance has displayed inconsistency in the reported periods. The indicated asking price seems ambitious given its historical financial data. The limited equity post-IPO suggests a lengthier timeline for transitioning to the mainboard. Opting to avoid this investment, characterized as a “High Risk/Low Return” proposition, might be a prudent choice.

SAROJA Pharma Industries IPO Subscription Status (Bidding Detail)

As of August 31, 2023:

  • The Saroja Pharma Industries IPO has been subscribed 0.79 times in total.
  • In the retail category, the subscription is 1.58 times.
  • In the Other category, the subscription is 0.11 times.

Check Day by Day Subscription Details (Live Status)

Saroja Pharma Industries SME GMP

The IPO till now there is no data is currently available.

check live Gmp details(status)

For more IPO related content like this stay tuned with ipohunts.

for previous financial blog about CPS sharpers click here.

If you are Interested in cricket buzzers and updates then make sure to check out crikzone.

if you are interested in Politics ,Football, technology make sure to check out blogsroom.


The content provided here should not be interpreted as an invitation or solicitation to buy or sell securities, nor should it be regarded as guidance for such actions. All material presented is intended solely for educational and informational purposes and should not be utilized for making investment choices in any manner. It is imperative to recognize that any data shared here carries no intent to influence investment decisions. Any individual considering investment moves should first seek guidance from a qualified financial advisor, taking into account the particulars of their circumstances.

It is vital to underscore that any decisions based on the information shared here are undertaken at one’s own risk. As with all investments in the stock market, it’s important to acknowledge the inherent and unpredictable risks associated with such endeavors.

One thought on “7 things to know before Saroja Pharma Industries India Limited

Leave a Reply

Your email address will not be published. Required fields are marked *